It has been confirmed that CDK4 and CDK6 are closely related to tumorigenesis [36, 37], and inhibition of CDK4/6 could bring an anti-tumor effect in several tumors [38, 39], including lymphoma [40, 41]. The gene discussed is CDK4; the disease is neoplasm.